To assess the effects of leptin in the tumor microenvironment, we generated an aggressive PTEN/BRAF melanoma line overexpressing leptin, as well as an oncolytic strain of Vaccinia virus engineered to induce tumor-specific secretion of leptin. This evidence concerns the gene LEP and neoplasm.